definiens: means either ( a ) eptinezumab ( also referred to internally by Alder as ALD403 ), asdescribed in U.S. patent number 9,745,373 in any form or formulation [ * * * ] ; ( b ) any anti - CGRPantibody that is other than eptinezumab and is first discovered or first identified as of the EffectiveDate by Alder or its controlled ( as defined in Section 1.1 ) Affiliate ; or ( c ) any antigen - bindingfragment of an anti - CGRP antibody described in clause ( a ) or ( b ) . [ * * * ] 1.3 means ( a ) a pharmaceutical product, in any mode of administration, that contains anAlder Antibody, [ * * * ], and ( b ) any Generic Product commercialized in the Territory by Alder, itsAffiliates or sublicensees . [ * * * ] 1.4 means a biologics license application, as described in the FDA regulations to obtainmarketing approval for a biological product in the United States, including all amendments andsupplements to the application, and any equivalent filing with any Regulatory Authority.1